1. Home
  2. RGNT vs PCLA Comparison

RGNT vs PCLA Comparison

Compare RGNT & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

N/A

Current Price

$1.31

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Logo PicoCELA Inc. American Depositary Shares

PCLA

PicoCELA Inc. American Depositary Shares

HOLD

Current Price

$7.50

Market Cap

13.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
RGNT
PCLA
Founded
2004
2008
Country
Israel
Japan
Employees
8
55
Industry
Biotechnology: Pharmaceutical Preparations
Building Products
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
11.1M
13.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RGNT
PCLA
Price
$1.31
$7.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
24.5K
1.9M
Earning Date
05-05-2026
02-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.54
$0.12
52 Week High
$8.35
$14.10

Technical Indicators

Market Signals
Indicator
RGNT
PCLA
Relative Strength Index (RSI) 25.56 59.28
Support Level N/A $0.75
Resistance Level $3.35 $8.00
Average True Range (ATR) 0.25 2.26
MACD -0.02 0.13
Stochastic Oscillator 1.56 46.55

Price Performance

Historical Comparison
RGNT
PCLA

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About PCLA PicoCELA Inc. American Depositary Shares

PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.

Share on Social Networks: